165 related articles for article (PubMed ID: 38244494)
1. Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis.
Zhao RR; Wu JH; Tong LW; Li JY; Lu YS; Shao JW
J Colloid Interface Sci; 2024 Apr; 660():257-276. PubMed ID: 38244494
[TBL] [Abstract][Full Text] [Related]
2. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
3. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A
ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789
[TBL] [Abstract][Full Text] [Related]
4. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis.
Li T; Huang HY; Qian B; Wang WH; Yuan Q; Zhang HY; He J; Ni KJ; Wang P; Zhao ZY; He JL; Fu SW; Xu L; Lin YC; Lin ZN
Free Radic Biol Med; 2024 Feb; 212():360-374. PubMed ID: 38171407
[TBL] [Abstract][Full Text] [Related]
5. Dual-drug controllable co-assembly nanosystem for targeted and synergistic treatment of hepatocellular carcinoma.
Le JQ; Song XH; Tong LW; Lin YQ; Feng KK; Tu YF; Hu YS; Shao JW
J Colloid Interface Sci; 2024 Feb; 656():177-188. PubMed ID: 37989051
[TBL] [Abstract][Full Text] [Related]
6. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.
Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W
Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic Dendrimer Doping Enhanced pH-Sensitivity of Liposomal Vesicle for Effective Co-delivery toward Synergistic Ferroptosis-Apoptosis Therapy of Hepatocellular Carcinoma.
Su Y; Zhang Z; Lee LTO; Peng L; Lu L; He X; Zhang X
Adv Healthc Mater; 2023 Jan; 12(6):e2202663. PubMed ID: 36653312
[TBL] [Abstract][Full Text] [Related]
8. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
Liu X; Zhu X; Qi X; Meng X; Xu K
Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
[TBL] [Abstract][Full Text] [Related]
9. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
10. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
11. pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors.
Sun R; Ma W; Ling M; Tang C; Zhong M; Dai J; Zhu M; Cai X; Li G; Xu Q; Tang L; Yu Z; Peng Z
J Control Release; 2022 Oct; 350():525-537. PubMed ID: 36055597
[TBL] [Abstract][Full Text] [Related]
12. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
[TBL] [Abstract][Full Text] [Related]
13. Three-pronged attacks by hybrid nanoassemblies involving a natural product, carbon dots, and Cu
Lai CM; Xu J; Zhang BC; Li DM; Shen JW; Yu SJ; Shao JW
J Colloid Interface Sci; 2023 Nov; 650(Pt A):526-540. PubMed ID: 37423180
[TBL] [Abstract][Full Text] [Related]
14. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
[TBL] [Abstract][Full Text] [Related]
15. Anti-PD-L1 DNAzyme Loaded Photothermal Mn
Liu P; Shi X; Peng Y; Hu J; Ding J; Zhou W
Adv Healthc Mater; 2022 Apr; 11(8):e2102315. PubMed ID: 34841741
[TBL] [Abstract][Full Text] [Related]
16. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
[No Abstract] [Full Text] [Related]
18. A cascaded copper-based nanocatalyst by modulating glutathione and cyclooxygenase-2 for hepatocellular carcinoma therapy.
Tian H; Zhao S; Nice EC; Huang C; He W; Zou B; Lin J
J Colloid Interface Sci; 2022 Feb; 607(Pt 2):1516-1526. PubMed ID: 34592546
[TBL] [Abstract][Full Text] [Related]
19. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
[TBL] [Abstract][Full Text] [Related]
20. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]